Merlin I – Release Me, A4 Print (21×29.7cm) – Edition of 100

Within “Merlin I – Release Me” artist Celeste Wrona has intertwined both a representation of the physical aspects of the cancer cell as seen under the Merlin microscope as well as the emotional connections with cancer as a disease. The artwork is filled with hope for a future where we could break these cells down […]

Within “Merlin I – Release Me” artist Celeste Wrona has intertwined both a representation of the physical aspects of the cancer cell as seen under the Merlin microscope as well as the emotional connections with cancer as a disease.

The artwork is filled with hope for a future where we could break these cells down and finally see the end of them. The gorgeous lines and patterns of the cell wall floating through the artwork and are a symbol for of the web that cancer tangles its victims and their family up in. This layer is represented free flowing almost like a ribbon blowing in the wind to be symbolic of the look towards the future of our ability to one day see the destruction of this disease and this vicious web of heartache and struggle come to a release and an end.

The inner cell is represented with beautiful, vibrant textures and colours, In this section the artist takes on the feelings and mind of the scientist and reflecting on their absolute awe and amazement that their hard work and research coming to fruition and how beautiful and comforting to them it must be to know they can now see cancer closer and in more detail than ever before. Knowing how much this will help those suffering and help move forward in the fight and hopefully win with cancer. These colours and textures that mimic the structures within the cell sparkle like jewels filled with promise and hope.

Limited edition fine art giclee print on Hahnemuhle Rag 308gsm archival paper. Sold unframed, signed and numbered by the artist.

Prints are made to order. Delivery time is 2-3 weeks Australia wide. For postage outside of Australia please request a quote.

The artist has agreed to share 50% of profits with the Ingham Institute for Applied Medical Research.

Share this post

No comments


Leave a Comment